Executioner CASP3, commonly used as a marker for the efficacy of cancer treatment, is involved in modulating colon cancer cell survival, proliferation, apoptosis, migration, invasion, and metastasis [90,91]. The gene discussed is CASP3; the disease is malignant colon neoplasm.